BlackRock, Inc.

13F Holdings History for Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

Symbol: DAWN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 5.85M shares
Security Ownership: 5.8%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in Day One Biopharmaceuticals, Inc. Common Stock, par value $0.0001 per share (DAWN)

2025-07-17 - BlackRock, Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.85M shares of Day One Biopharmaceuticals, Inc. Common Stock, par value $0.0001 per share (DAWN). This represents 5.8% percent ownership of the company. In their previous filing dated 2025-04-28, BlackRock, Inc. had reported owning 4.81M shares, indicating an increase of 21.6% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BlackRock, Inc.	5.8%	+22%	$37.7M	5.85M	+1,037,610	+21.6%	$6.45	13G	6/30/2025	17 Jul 2025 19:54:38
BlackRock, Inc.	4.7%		$34.3M	4.81M			$7.12	13G/A	3/31/2025	28 Apr 2025 17:45:59

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	+0%	$63.9M	9.83M	+3,072,502	+45.5%	$6.50	Q2 2025
3/31/2025	0%	+0%	$53.6M	6.76M	+602,092		$7.93	Q1 2025
12/31/2024	0%	+0%	$78M	6.16M	+1,446,675	+30.7%	$12.67	Q4 2024
9/30/2024	0%		$65.6M	4.71M			$13.93	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.